Individual and neighbourhood socioeconomic inequalities in cognitive impairment: cross-sectional findings from the French CONSTANCES cohort.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 03 2020
Historique:
entrez: 21 3 2020
pubmed: 21 3 2020
medline: 16 4 2021
Statut: epublish

Résumé

Despite the recent awareness of the environment impact on brain ageing, the influence of the neighbourhood socioeconomic status on cognitive impairment remains unclear. Here, we investigated the effects of individual and neighbourhood deprivation on cognitive impairment in middle-aged and young-old people. Cross-sectional study. 21 Health Screening Centres in the entire French metropolitan territory. A total of 44 648 participants (age range: 45 to 69 years) from the French CONSTANCES cohort were included in the analyses. Associations between the overall cognitive score (based on a standardised battery of cognitive tests administered by neuropsychologists) and individual deprivation (Evaluation of Deprivation and Inequalities in Health Screening Centres; EPICES score) and geographical deprivation (French Deprivation Index; FDep index). Based on the EPICES score (validated cut-off ≥30.17), 12% of participants were considered to be deprived. After mutual adjustment, individual and geographical deprivation were associated with higher cognitive impairment in a multilevel logistic regression analysis that was also adjusted for sociodemographic, lifestyle and health factors. Specifically, individual deprivation was associated with an odds increase of 55% (OR=1.55, 95% CI: 1.45 to 1.66). The risk of global cognitive impairment progressively increased with the neighbourhood deprivation level, evaluated by the FDep index (reference Q1; Q2: OR=1.09, 95% CI: 0.98 to 1.20; Q3: OR=1.15, 95% CI: 1.04 to 1.27; Q4: OR=1.15, 95% CI: 1.04 to 1.28; Q5: OR=1.25, 95% CI: 1.13 to 1.39). Our results suggest that the neighbourhood socioeconomic deprivation level is associated with cognitive impairment, independently of the individual deprivation level. A better understanding of this association could help to define new prevention strategies to target high-risk residents and high-risk geographical areas in order to reduce social health inequalities.

Identifiants

pubmed: 32193263
pii: bmjopen-2019-033751
doi: 10.1136/bmjopen-2019-033751
pmc: PMC7150592
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e033751

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Environ Health Perspect. 2018 Jul 12;126(7):077003
pubmed: 30028296
Stat Med. 2017 Sep 10;36(20):3257-3277
pubmed: 28543517
J Gerontol B Psychol Sci Soc Sci. 2020 Jan 1;75(1):218-227
pubmed: 29077923
Am J Epidemiol. 2009 May 1;169(9):1092-101
pubmed: 19270047
Am J Prev Med. 2017 Aug;53(2):241-251
pubmed: 28455123
BMC Geriatr. 2016 Oct 12;16(1):175
pubmed: 27729011
Health Aff (Millwood). 2002 Mar-Apr;21(2):31-46
pubmed: 11900185
BMJ. 2013 Dec 19;347:f7051
pubmed: 24355614
Alzheimers Dement. 2018 Apr;14(4):473-482
pubmed: 29102501
Dement Geriatr Cogn Disord. 2019;47(4-6):297-305
pubmed: 31466055
JAMA Psychiatry. 2018 Jul 1;75(7):723-732
pubmed: 29799983
Ageing Res Rev. 2015 Sep;23(Pt B):167-82
pubmed: 26144974
Am J Epidemiol. 2011 May 15;173(10):1148-58
pubmed: 21430188
J Epidemiol Community Health. 2007 Jun;61(6):466-7
pubmed: 17496251
Int J Epidemiol. 2012 Aug;41(4):1012-32
pubmed: 22798662
Brain. 2014 Apr;137(Pt 4):1167-75
pubmed: 24578544
J Epidemiol Community Health. 2012 Aug;66(8):730-6
pubmed: 21515547
Eur J Neurol. 2016 Nov;23(11):1614-1626
pubmed: 27435355
Eur J Public Health. 2015 Aug;25(4):604-9
pubmed: 25624273
Eur J Epidemiol. 2015 Dec;30(12):1317-28
pubmed: 26520638
BMC Public Health. 2009 Jan 22;9:33
pubmed: 19161613
Eur J Neurol. 2019 May;26(5):786-793
pubmed: 30575234
Circulation. 2015 Sep 1;132(9):873-98
pubmed: 26240271
J Frailty Aging. 2016;5(3):168-173
pubmed: 29240316
Soc Sci Med. 2017 Jan;172:56-63
pubmed: 27886528
Am J Epidemiol. 2016 Jun 15;183(12):1088-97
pubmed: 27257114
Public Health Rep. 2014 Jan-Feb;129 Suppl 2:19-31
pubmed: 24385661
BMC Geriatr. 2019 Jan 7;19(1):4
pubmed: 30616586
JAMA Neurol. 2017 Oct 1;74(10):1246-1254
pubmed: 28783817
Front Psychol. 2016 Aug 30;7:1329
pubmed: 27625629
Am J Epidemiol. 2001 Feb 15;153(4):363-71
pubmed: 11207154
Ann Epidemiol. 2015 Nov;25(11):849-54
pubmed: 26253697
J Am Geriatr Soc. 2008 Feb;56(2):191-8
pubmed: 18179489
Soc Psychiatry Psychiatr Epidemiol. 2015 Mar;50(3):351-62
pubmed: 25087013
Arch Gen Psychiatry. 2011 Mar;68(3):314-21
pubmed: 21383266
Curr Alzheimer Res. 2015;12(4):350-7
pubmed: 25817251
Nat Neurosci. 2015 Oct;18(10):1421-31
pubmed: 26404717
Sante Publique. 2006 Dec;18(4):513-22
pubmed: 17294755

Auteurs

Noémie Letellier (N)

Neuropsychiat Epidemiol & Clin Res, Univ Montpellier, INSERM, Montpellier, France noemie.letellier@inserm.fr.

Isabelle Carrière (I)

Neuropsychiat Epidemiol & Clin Res, Univ Montpellier, INSERM, Montpellier, France.

Emmanuelle Cadot (E)

IRD - Hydrosciences UMR 5569, Montpellier University, Montpellier, France.

Lisa Berkman (L)

Harvard Center for Population and Development Studies, Harvard University, Cambridge, Massachusetts, USA.

Marcel Goldberg (M)

Paris Descartes University, Paris, France.
INSERM, Population-Based Epidemiological Cohorts Research Unit, UMS 011, Villejuif, France.

Marie Zins (M)

Paris Descartes University, Paris, France.
INSERM, Population-Based Epidemiological Cohorts Research Unit, UMS 011, Villejuif, France.
UVSQ, INSERM, VIMA; Aging and chronic diseases, U1168, Villejuif, France.

Claudine Berr (C)

Neuropsychiat Epidemiol & Clin Res, Univ Montpellier, INSERM, Montpellier, France.
Memory Research and Resources Center, Department of Neurology, Montpellier University Hospital Gui de Chauliac, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH